{"id":"W4280592992","doi":"10.1093/rheumatology/keac300","title":"Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis","year":2022,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada); Toronto Western Hospital; University of Toronto; Mount Sinai Hospital","funders":"National Institute for Health and Care Research; GlaxoSmithKline","keywords":"Medicine; Placebo; Tolerability; Clinical endpoint; Internal medicine; Adverse effect; Randomized controlled trial; Cohort; Clinical trial; Gastroenterology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00103783,0.0002027098,0.001548247,0.0001817669,0.0001053425,0.00001820081,0.0001573657,0.0001384844,0.0001399375],"category_scores_gemma":[0.0003090709,0.0001431396,0.000193612,0.0003153723,0.0001546391,0.0000660172,0.0001567607,0.000364956,0.000004028825],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004834403,"about_ca_system_score_gemma":0.00008693285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006862468,"about_ca_topic_score_gemma":0.00001223314,"domain_scores_codex":[0.995666,0.001912064,0.001267026,0.0005535505,0.0004018537,0.0001994865],"domain_scores_gemma":[0.9981845,0.0008302487,0.0003452875,0.000369882,0.00005774481,0.0002123501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1146651,0.02511178,0.7355357,0.00008184819,0.001384807,0.0005861863,0.006340033,0.00008198759,0.1101778,0.00004663414,0.00009739742,0.005890637],"study_design_scores_gemma":[0.5012578,0.004204813,0.4735246,0.0008334049,0.0006939078,0.00006272764,0.0143694,0.004531084,0.0001650237,0.0000626631,0.0000182905,0.0002763584],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905093,0.007053236,0.000009907956,0.00004175557,0.0002585054,0.001921939,0.0001149904,0.00003865752,0.00005165985],"genre_scores_gemma":[0.9981879,0.001123809,0.00009445007,0.00009939112,0.0001109353,0.0001257899,0.0002292541,0.00001994675,0.000008548202],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3865927,"threshold_uncertainty_score":0.5837063,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05882782610824001,"score_gpt":0.3536563620890277,"score_spread":0.2948285359807877,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}